Kathryn J. Ruddy, M.D.

  1. Oncologist

Departments

Specialty Groups

Location

  1. Rochester, Minnesota

Languages

English

Kathryn J. Ruddy is a medical oncologist who sees patients with breast cancer. She has particular expertise in:

  • Premenopausal breast cancer
  • Male breast cancer
  • Survivorship issues including fertility preservation
  • Management of side effects of treatment

In addition to her clinical activities, Dr. Ruddy co-leads the Mayo Clinic Comprehensive Cancer Center Symptom Control/Survivorship Cross-Disciplinary Group, and she is active in research focused on prediction and prevention of toxicity in patients with cancer, and patient-reported outcomes during and after cancer treatment. She mentors residents and fellows, speaks at national meetings, and publishes in high-impact scientific journals.

  1. Cancer survivorship program
  2. Cancer treatment
  • Breast cancer
  • Cancer survivorship
  • Long-term and late toxicities of cancer therapy (including infertility)
  • Breast cancer in young women
  • Breast cancer in men
Rochester

Rochester, Minnesota

  1. 2009
    Fellow - Medical Oncology and HematologyDana-Farber Cancer Institute
  2. 2008
    MPH - Clinical EffectivenessHarvard School of Public Health
  3. 2006
    Resident - Internal MedicineMassachusetts General Hospital
  4. 2003
    MD - MedicineUniversity of Pennsylvania
  5. 1999
    AB - Summa Cum Laude, Psychology and Biology(cognitive neuroscience)Harvard College

Certifications

  1. 2009
    Medical OncologyAmerican Board of Internal Medicine

Awards and honors

  1. 2012
    Physician of the YearCancerCare
  2. 2003
    Alpha Omega AlphaUniversity of Pennsylvania School of Medicine
  3. 1999
    Gamble ScholarUniversity of Pennsylvania School of Medicine (merit-based full scholarship)
  4. 1998
    Phi Beta KappaHarvard College

Professional memberships

  1. 2023 - 2024
    Moonshot Scholars Diversity Program ReviewNCI Special Emphasis Panel
  2. 2023 - present
    Workgroup MemberAmerican Cancer Society, National Breast Cancer Roundtable, Access to Treatment Workgroup
  3. 2023
    Grant Review Panel MemberNCI Cancer Moonshot Scholars Diversity Program
  4. 2023 - present
    Associate Chair of Healthcare Delivery, Supportive care, and Health Disparities Research ChairExecutive Committee, Department of Oncology
  5. 2022 - present
    Member and ReviewerKL2 Scientific Review Committee
  6. 2022 - present
    Annual Meeting Education Committee MemberAmerican Society of Clinical Oncology
  7. 2022 - present
    site PITranslational Breast Cancer Research Consortium (TBCRC)
  8. 2022 - 2025
    Health Services Research and Quality Improvement trackASCO Annual Meeting Education Committee
  9. 2022 - 2023
    Equity Scorecard Task ForceAmerican Society of Clinical Oncology
  10. 2022 - present
    Leader of Survivorship/Surveillance Subgroup of MCCC Practice IntegrationMayo Clinic Cancer Center
  11. 2021
    Academic PanelistCardiology Oncology Innovation Network (COIN)
  12. 2021
    Grant ReviewerCenter for Clinical and Translational Science (CCaTS)
  13. 2021
    R21/R03 Grant ReviewerNational Institutes of Health
  14. 2021 - present
    Member, Women's Cancer ProgramMayo Clinic Cancer Center
  15. 2021
    ChairPatient and Community Education Subcommittee, Mayo Clinic Cancer Center
  16. 2021 - present
    Health Equity and Outcomes Committee MemberAmerican Society of Clinical Oncology
  17. 2021 - present
    MemberMinnesota Society of Clinical Oncology (MSCO)
  18. 2021
    Session ChairCharité Mayo Conference
  19. 2021 - present
    MemberAmerican Society of Preventative Oncology
  20. 2021 - present
    Special expertNCI Breast Cancer Steering Committee
  21. 2021 - present
    MemberAmerican College of Cardiology
  22. 2021 - present
    Co-ChairAlliance for Clinical Trials in Oncology
  23. 2020 - present
    MCCC Transformation Workstream MemberMayo Clinic Cancer Center
  24. 2020 - present
    MemberAmerican Association for Cancer Research
  25. 2020 - present
    LeaderCancer Patient Education Center Internal Advisory Group
  26. 2020 - 2022
    Vice Chair of Neuro complications committeeMultinational Association of Supportive Care in Cancer
  27. 2020 - 2023
    Cancer Survivorship Committee MemberAmerican Society of Clinical Oncology
  28. 2020 - present
    Breast Cancer Advisory Group MemberAmerican Society of Clinical Oncology
  29. 2020 - 2021
    MemberMayo Clinic International
  30. 2020 - present
    MemberMoonshot Team
  31. 2020 - present
    Co-Leader of Population Sciences ProgramMayo Clinic Cancer Center
  32. 2020 - present
    Search Committee Member of Population Science ProgramMayo Clinic Cancer Center
  33. 2019
    Expert PanelistSan Antonio Breast Cancer Symposium (SABCS)
  34. 2019 - 2020
    Leadership Development Program MemberAmerican Society of Clinical Oncology
  35. 2019 - present
    LeaderMayo Clinic Breast eTumor Board
  36. 2018
    MentorSan Antonio Breast Cancer Symposium (SABCS)
  37. 2018 - 2020
    Expert PanelistAmerican Society of Clinical Oncology
  38. 2018 - present
    ChairBreast eTumor, Mayo Clinic eBoard
  39. 2017
    Expert PanelistFood and Drug Administration (FDA)
  40. 2017 - 2019
    Member of Patient Engagement WorkgroupMayo Clinic Cancer Center
  41. 2017
    Co-LeaderCancer Control Disease-Oriented Group
  42. 2017 - present
    Leader of Symptom Control and Survivorship Cross-Disciplinary GroupMayo Clinic Cancer Center
  43. 2016
    MentorSan Antonio Breast Cancer Symposium (SABCS)
  44. 2016 - present
    Member Education Committee/IMP Education CommitteeMayo Clinic Cancer Center
  45. 2016 - present
    Invited MemberYoung Survival Coalition
  46. 2016 - 2020
    LeadTranslational Breast Cancer Research Consortium (TBCRC)
  47. 2016 - 2017
    MemberMinnesota Cancer Alliance
  48. 2016 - 2018
    MemberDepartment of Medical Oncology
  49. 2016 - 2017
    Co-Leader of Survivorship Standards CouncilMayo Clinic Cancer Center
  50. 2016 - present
    Co-Leader Questionnaires and Patient Reported Outcomes Working GroupDepartment of Oncology
  51. 2015 - present
    Advisory Panel MemberPsychosocial Oncology, Cancer.net, American Society of Clinical Oncology
  52. 2015
    Program DirectorCardio-Oncology Program
  53. 2015
    Co-authorBreast Specialty Council Workgroup
  54. 2015 - 2017
    ChairAmerican Society of Clinical Oncology
  55. 2015 - 2016
    MemberCenter for the Science of Health Care Delivery
  56. 2015 - present
    Advisory PanelistPsychosocial Oncology
  57. 2014 - present
    MemberMultinational Association of Supportive Care in Cancer
  58. 2014 - 2022
    MemberNational Comprehensive Cancer Network
  59. 2014 - 2021
    Vice ChairAlliance, Symptom Intervention Committee
  60. 2014 - present
    MemberAmerican College of Surgeons
  61. 2013 - 2016
    MemberCancer Control Disease-Oriented Group
  62. 2013 - present
    Executive Committee MemberBreast Disease Registry
  63. 2013 - present
    InterviewerDepartment of Internal Medicine
  64. 2013 - present
    InterviewerHarvard College
  65. 2013 - present
    Co-ChairEORTC 10085 Male Breast Cancer QoL Working Group
  66. 2013 - present
    MemberAmerican Medical Women's Association
  67. 2013 - present
    MemberAmerican Society of Breast Disease
  68. 2012
    Project OfficerBrigham and Women's Hospital
  69. 2011 - 2015
    MemberAlliance, Committee on Advocacy Research Communications, Ethics and Disparities (CARE)
  70. 2011 - 2013
    ASCO RepresentativeAmerican Society of Plastic Surgeons
  71. 2011
    FacilitatorBrigham and Women's Hospital
  72. 2011
    RepresentativeAmerican Association for Cancer Research & American Society of Clinical Oncology
  73. 2010 - 2013
    MemberCancer and Leukemia Group B Foundation
  74. 2007 - present
    MemberAmerican Society of Clinical Oncology
  75. 2006 - 2010
    MemberMassachusetts Medical Society
  76. 2005 - 2006
    MemberEducation at MGH(ECOTE), Massachusetts General Hospital
  77. 2004 - 2005
    MemberEducation at MGH(ECOTE), Massachusetts General Hospital